QA: Bioxytran INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2019_Bioxytran_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 36,411
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 261,725
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 214,710
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 9,369
11 remainder_Revenues -39,390
12 remainder_NetIncome -57,132
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 36,411
1 Liabilities 261,725
2 Expenses 224,079
3 Revenues -39,390
4 StockholdersEquity -225,314
5 NetIncome -320,601
6 ComprehensiveNetIncome -320,601
7 BaseVar 309,368
8 EconomicCapitalRatiobeforeLimitedLiability -5.45
9 EconomicCapitalRatio 0.132

Edgar->Model Mapping

Feature Distribution

Change over Time